GSK announces FDA approval for Nucala (mepolizumab) for use in adults with chronic rhinosinusitis with nasal polypsBusiness Wire • 07/29/21
GlaxoSmithKline's (GSK) CEO Emma Walmsley on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 07/28/21
Vaccine Demand Boosts GlaxoSmithKline's Q2 Sales, Earnings; Maintains FY21 GuidanceBenzinga • 07/28/21
GlaxoSmithKline: This is what one leading Wall Street bank thinks of the CEO's plansProactive Investors • 07/06/21